Q: This offering by SHOP, is it similar to a bought deal, or is it more like what DOO did in September when major shareholders sold some of their shares.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I've done pretty well by simply selling short any company targeted by Spruce Point. XPO is their latest target. It's already had a bad day. What are your thoughts on a short at this entry point? Thank you as always in advance for your answer.
Jason
Jason
Q: Hi 5i,
Can you explain what this offering by SHOP means? There’s no price listed?
Thanks!
Dave
Can you explain what this offering by SHOP means? There’s no price listed?
Thanks!
Dave
Q: What do you think will happen at DGC now that the board has been changed so dramatically ? If it is sold your thoughts on a premium price over todays eleven bucks. THANKS
Q: why did tfii drop so much today? Also when do you think there will be a turn around in the market. I know this is not an easy question and there are many factors. T Steve
Q: comments on the latest quarter please ?
Q: Could you please comment on TCL.a results, with special reference to progess on Coveris acquisition. Do you see stock rebound in near term ? Thanks
Q: I’m getting slaughtered on this one. Hang in?
Q: Would you say this is an accurate way to characterize Knight Therapeutics?
The Globe and Mail reports in its Monday edition that the markets are on edge and trend followers are running for the exits. The Globe's Norman Rothery writes in the Inside the Market column that it is hard for companies to raise money while fear stalks the land. Mr. Rothery says they risk becoming zombie stocks that shamble around a bit before keeling over. He says even in good times, firms with negative earnings fare poorly and are, as a group, best avoided. For the current column, Mr. Rothery says he focused on stocks that are, potentially, in much more dire circumstances. To find them he looked at earnings before interest, taxes, depreciation and amortization or EBITDA. It is bad enough to fall into the red after paying normal and recurring business expenses such as interest and taxes and other expenses; it can be deadly having negative earnings even before these essentials are paid for. Companies with negative EBITDAs are in a particularly precarious position and may be zombies. Matters get worse when the markets tumble and it becomes next to impossible to borrow money or to sell stock. Mr. Rothery's potential zombie stocks are Hexo, Knight Therapeutics, Advanz Pharma, Katanga Mining and Paramount Resources.
Thanks as always,
Rob
The Globe and Mail reports in its Monday edition that the markets are on edge and trend followers are running for the exits. The Globe's Norman Rothery writes in the Inside the Market column that it is hard for companies to raise money while fear stalks the land. Mr. Rothery says they risk becoming zombie stocks that shamble around a bit before keeling over. He says even in good times, firms with negative earnings fare poorly and are, as a group, best avoided. For the current column, Mr. Rothery says he focused on stocks that are, potentially, in much more dire circumstances. To find them he looked at earnings before interest, taxes, depreciation and amortization or EBITDA. It is bad enough to fall into the red after paying normal and recurring business expenses such as interest and taxes and other expenses; it can be deadly having negative earnings even before these essentials are paid for. Companies with negative EBITDAs are in a particularly precarious position and may be zombies. Matters get worse when the markets tumble and it becomes next to impossible to borrow money or to sell stock. Mr. Rothery's potential zombie stocks are Hexo, Knight Therapeutics, Advanz Pharma, Katanga Mining and Paramount Resources.
Thanks as always,
Rob
Q: ClIQ continues its decent closing @ $616(1 yr low $6.06),After close today announced termination of Div.,& capx for next 2/3yrs.Your take please.Txs for U usual great services & views
Q: If i buy a stock on the 19th and the ex dividend date is the 20th will i recieve the dividend for that month ? Or is it not considerd bought until the settlement date?
Q: Hi - I have no REIT exposure and am considering adding either VRE or XRE. They are both promoted as tracking the TSX/S&P capped REIT index. When I overlay a graph of their 2 year price performance sure enough they are virtually identical. At first glance it would seem a no brainer to go with VRE since the MER is 1/2 that of XRE (.35% vs. 61%). However, it also appears XRE pays a substantially higher dividend ( ~ 4.7% vs. ~ 3% depending on the source I check). Can you shed any light on why the difference in the dividend when they are both tracking the same index? Do you have a preference for one over the other? Thank You
Q: Crypto mining has driven NVDA's stock price for some years now, but its currencies' decline will surely take a heavy toll on GPU sales into that market. Yes, AI and autonomous vehicle applications could expand, and consumers will continue to play video games, but are these enough to create actual earnings growth, or is NVDA more likely to tread water for a few years?
-
Canadian Apartment Properties Real Estate Investment Trust (CAR.UN)
-
CT Real Estate Investment Trust (CRT.UN)
Q: The new equity issue by CAR.UN was priced almost $2 below recent trading range - and the market opened the next day with an immediate drop to match. CRT.UN did a similar move a month or so ago - with a corresponding immediate price drop. This appears to be a common industry practice - but that alone does not make it ethically right. I have been burned many times by this. Why are new equity issues not priced more in line with current trading range (e.g. to match closing price on the prior trading day)? Isn't it the duty of the regulator to block transactions that are priced to influence (i.e. manipulate) the market?
Q: Hi 5i,
I noticed that your recent answer to a question on Tencent came up under the TCEHY symbol for over the counter trading. The company is now trading on the NYSE under the symbol TME, which should make a better market for it in North America and free it up from the warnings about RSP suitability that usually come up with the over the counter stuff. Cheers!
I noticed that your recent answer to a question on Tencent came up under the TCEHY symbol for over the counter trading. The company is now trading on the NYSE under the symbol TME, which should make a better market for it in North America and free it up from the warnings about RSP suitability that usually come up with the over the counter stuff. Cheers!
Q: Can you please coment on the proposed tax efficientiancy promoted by horizon.ie total return distribution yearly if any.does it mean you only have capital gains to be reported? Great service and tks
Q: According to a Morningstar report, year to date earnings per share are negative; yet another report I saw seems to contradict this. What do you see as this year's EPS?
Also what is your current projection for earnings over the next two years? And what are possible events that could affect your estimates either up or down?
Also what is your current projection for earnings over the next two years? And what are possible events that could affect your estimates either up or down?
Q: Something is not right here. A company doesn't drop 55% in a few months and continues to drop almost daily without a reason. Something is happening behind the scenes that is causing this.
Q: I know that there isn 30 day time limit on margin accounts. Are RRSPandTFSA accounts also @ 30 day limit.Thanks for your great service. Jim
Q: ALA: Sorry, another question about ALA. I just want to confirm: Is your best advice to sell ALA, take the loss (in my non-registered account) and move on, despite the 50% loss in share price? Besides ENB as an alternative for a long term income objective, what other quality stocks would you recommend now?